ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1677

$1.27M Total Retail Price of All Prescriptions

Rank: 34 out of 1677

925 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 925 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 925 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 22,772 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 1,075 928 1 1
OMEPRAZOLE 943 736 2 6
AMLODIPINE BESYLATE 847 773 3 2
HYDROCODONE-ACETAMINOPHEN 830 553 S3 4 4
FUROSEMIDE 784 711 5 8
LISINOPRIL 754 606 6 3
HYDROCHLOROTHIAZIDE 666 588 7 9
LEVOTHYROXINE SODIUM 636 532 8 5
METFORMIN HCL 526 432 9 7
POTASSIUM CHLORIDE 490 425 10 14
LOSARTAN POTASSIUM 418 387 11 25
CARVEDILOL 408 363 12 20
BENAZEPRIL HCL 399 353 13 53
PRAVASTATIN SODIUM 394 357 14 10
PREDNISONE 387 313 15 40
RANITIDINE HCL 363 282 16 18
METOPROLOL TARTRATE 362 321 17 12
TRAMADOL HCL 354 271 18 16
ZOLPIDEM TARTRATE 349 244 19 15
ATORVASTATIN CALCIUM 344 292 20 13
METOPROLOL SUCCINATE 318 279 21 23
WARFARIN SODIUM 316 307 22 24
GLIMEPIRIDE 281 238 23 33
CITALOPRAM HBR 269 227 24 22
GABAPENTIN 267 207 25 11
LOVASTATIN 244 204 26 35
DONEPEZIL HCL 231 231 27 30
CLOPIDOGREL 217 175 28 32
SERTRALINE HCL 210 164 29 26
AMOXICILLIN 203 167 30 94
BYSTOLIC 200 200 31 125
ATENOLOL 191 162 32 21
SPIRONOLACTONE 186 175 33 88
CYCLOBENZAPRINE HCL 183 111 R 34 52
NAMENDA 183 183 34 39
TRAZODONE HCL 179 107 36 37
CRESTOR 177 153 37 28
DIOVAN 174 157 38 45
PANTOPRAZOLE SODIUM 172 112 39 46
NEXIUM 169 129 40 19
FLUTICASONE PROPIONATE 166 111 41 29
POLYETHYLENE GLYCOL 3350 163 142 42 76
ROPINIROLE HCL 155 118 43 79
MELOXICAM 154 129 44 27
TAMSULOSIN HCL 149 127 45 34
ALENDRONATE SODIUM 142 133 46 43
LEVEMIR 140 106 47 157
SYNTHROID 136 133 48 55
NAPROXEN 134 109 49 87
DIGOXIN 133 133 50 71
PROMETHAZINE HCL 133 98 R 50 64
PLAVIX 132 104 52 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 131 106 53 85
KLOR-CON M20 130 113 54 65
RISPERIDONE 125 113 55 60
ZETIA 124 96 56 75
ALLOPURINOL 123 102 57 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 71 58 17
TRIAMCINOLONE ACETONIDE 121 115 58 134
SPIRIVA 119 97 60 74
ESCITALOPRAM OXALATE 119 109 60 80
PROAIR HFA 116 60 62 50
NITROGLYCERIN PATCH 116 101 62 184
FLUOXETINE HCL 116 79 62 49
CIPROFLOXACIN HCL 114 99 65 57
CELEBREX 112 96 66 102
BENICAR 102 89 67 178
LANTUS 102 83 67 44
FENOFIBRATE 101 83 69 48
ADVAIR DISKUS 101 91 69 54
AMLODIPINE BESYLATE-BENAZEPRIL 100 91 71 59
PAROXETINE HCL 96 90 72 67
AZITHROMYCIN 96 68 72 38
ENALAPRIL MALEATE 95 81 74 82
MECLIZINE HCL 94 86 75 110
VERAPAMIL ER 93 77 76 86
AMITRIPTYLINE HCL 92 70 R 77 63
INSULIN SYRINGE 92 53 77 72
DILTIAZEM 24HR ER 91 87 79 144
LIPITOR 90 84 80 101
FENTANYL 87 66 S2 81 103
VENLAFAXINE HCL ER 86 49 82 92
NIASPAN 83 55 83 128
METOLAZONE 81 74 84 205
BENICAR HCT 81 65 84 194
TRICOR 81 54 84 100
CEPHALEXIN 80 68 87 99
LYRICA 78 53 88 81
LORAZEPAM 75 55 89 239
DIOVAN HCT 73 72 90 66
RIVASTIGMINE 71 71 91 271
BENAZEPRIL-HYDROCHLOROTHIAZIDE 70 69 92 139
OXYCODONE HCL-ACETAMINOPHEN 67 40 S2 93 115
TERAZOSIN HCL 67 67 93 138
LEVOFLOXACIN 66 51 95 84
QUETIAPINE FUMARATE 64 44 96 77
MIRTAZAPINE 64 64 96 62
DETROL LA 64 49 96 185
LOSARTAN-HYDROCHLOROTHIAZIDE 63 60 99 42
HYDRALAZINE HCL 62 60 100 69
JANUVIA 57 49 101 70
OXYBUTYNIN CHLORIDE 57 47 101 149
RAMIPRIL 56 46 103 118
EVISTA 56 56 103 162
BUPROPION HCL SR 56 55 103 188
DOXEPIN HCL 55 46 106 190
TRIAMTERENE-HCTZ 54 54 107 61
DICYCLOMINE HCL 54 45 107 196
AGGRENOX 52 49 109 191
CYMBALTA 52 32 109 58
ACTOS 52 36 109 104
DIVALPROEX SODIUM 51 51 112 111
OXYBUTYNIN CHLORIDE ER 51 36 112 173
METOCLOPRAMIDE HCL 51 36 112 124
DEXILANT 50 38 115 179
LEVEMIR FLEXPEN 50 39 115 207
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.